Characterization of 4-aminobiphenyl-hemoglobin adducts in maternal and fetal blood samples

Journal of Toxicology and Environmental Health - Part A

Volumn 47, Issue 6, 1996, Pages 553-566

  Myers, Steven R ^a   Spinnato, Joseph A ^a   Pinorini Godly, Maria T ^a   Cook, Curtis ^a   Boles, Brent ^a   Rodgers, George C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 BIPHENYLAMINE; CIGARETTE SMOKE; COTININE; HEMOGLOBIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; FETUS BLOOD; HUMAN; MATERNAL BLOOD; PREGNANCY; PRIORITY JOURNAL; PROTEIN BINDING; QUESTIONNAIRE; SMOKING;

AMINOBIPHENYL COMPOUNDS; BINDING, COMPETITIVE; CARCINOGENS; COHORT STUDIES; COTININE; DNA ADDUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FETAL BLOOD; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEMOGLOBINS; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; QUESTIONNAIRES; SMOKING;

EID: 0029921457     PISSN: 15287394     EISSN: None     Source Type: Journal    
DOI: 10.1080/009841096161537     Document Type: Article

References (37)

1. Bartsch, H., Caporaso, N., Coda, M., Kadlubar, F., Malaveille, C., Skipper, P., Talaska, G., Tannenbaum, S. R., and Vineis, P. 1990. Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolitic phenotype in active and passive cigarette smokers. J. Natl. Cancer Inst. 82:1826-1830.
2. Bryant, M. S., and Osterman-Golkar, S. 1991. Hemoglobin adducts as dosimeters of exposure to DNA-reactive chemicals. CIIT Activ. Rep. 11(10).
3. Bryant, M. S., Skipper, P. L., Tannenbaum, S. R., and Maclure, M. 1987. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer. Res. 47:602-608.
4. Bulay, O. M., and Wattenberg, L. W. 1970. Carcinogenic effects of subcutaneous administration of benzo(a)pyrene during pregnancy on the progeny. Proc. Soc. Exp. Biol. Med. 135:84-86.
5. Butler, M. A., Guengerich, F. P., and Kadlubar, F. F. 1989. Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4′-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monoxygenase. Cancer Res. 49:25-31.
6. Cartwright, R. A., Glashan, R. W., and Rogers, H. J. 1982. Role of N-acetyltransferase phenotypes in bladder carcinogenesis: A pharmacokinetic epidemiologic approach to bladder cancer. Lancet 2:842-848.
7. Castonguay, A., Tjalve, H., and Trushin, N. 1984. Perinatal metabolism of the tobacco specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in C7BL mice. J. Natl. Cancer Inst. 72:1117-1126.
8. Coghlin, J., Gann, P. H., Hammond, S. K., Skipper, P. L., Taghizadeh, K., Paul, M., and Tannenbaum, S. R. 1991. 4-Aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero. JNCI 83:274-280.
9. Correa, F., Joshi, P. A., and Castoguay, A. 1990. The tobacco specific nitrosamine 4-(methynitrosamino)-1-(3-pyridyl)-1-butanone is an active transplacental carcinogen in Syrian golden hamsters. Cancer Res. 50:3435-3438.
10. Del Santo, P., Moneti, G., Salvadori, M., Saltutti, C., Delle Rose, A., and Dolara, P. 1991. Levels of the adducts of 4-aminobiphenyl to hemoglobin in control subjects and bladder carcinoma patients. Cancer Lett. 60:245-251.
11. Druckrey, H., Preussman, R., and Ivankovis, S. 1969. N-nitroso compounds in organotropic and transplacental carcinogenesis. Ann. NY Acad. Sci. 163:676-696.
12. Ehrenberg, L., Moustacci, E., and Osterman-Golkar, S. 1983. International commission for protection against environmental mutagens and carcinogens. Dosimetry of enotoxic agents and dose response relationships of their efects. Mutat. Res. 123:121-182.
13. Everson, R. B. 1980. Individuals transplacentally exposed to maternal smoking may be at increased cancer risk in adult life. Lancet 1:123-127.
14. Everson, R. B., Randerath, E., and Santella, R. M. 1988. Quantitative associations between DNA damage in human placenta and maternal smoking and birth weight. Cancer Res. 80:567-576.
15. Janerich, D. T., Thompson, W. D., and Varela, L. R. 1990. Lung cancer and exposure to tobacco smoke in the household. N. Engl. J. Med. 323:632-636.
16. Kauffman, S. L. 1976. Susceptibility of fetal lung to transplacenal 1-ethyl-1-nitrosourea: Its relation to epithelial proliferation. J. Natl. Cancer Inst. 57:821-825.
17. 32P-Postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene. Cancer Res. 46:3046-3054.
18. Lucier, G. W., Lui, E. M. K., and Lamartiniere, C. A. 1979. Metabolic activation/deactivation reactions during perinatal development. Environ. Health Perspect. 29:7-16.
19. Manchester, D. K., and Jacoby, E. H. 1981. Sensitivity of human placental monoxygenase activity to maternal smoking. Clin. Pharmacol. Ther. 30:687-692.
20. 32P-postlabeling analysis of human placental DNA known to contain benzo(a)pyrene diol epoxide adducts. Carcinogenesis 7:2071-2075.
21. Mochizuki, M., Maruo, T., and Masuko, K. 1984. Effects of smoking on fetoplacental-maternal system during pregnancy. Am. J. Obstet. Cynecol. 149:413-420.
22. 6-methyl guanine-DNA methyltransferase and uracil-DNA glycosylase in human organs. Carcinogenesis 4:1565-1568.
23. Napalkov, N. P. 1973. Some general considerations on the problem of transplacental carcinogenesis. In Transplacental carcinogenesis, eds. L. Tomatis and U. Mohr, vol. 4, pp. 1-13. Lyon, France: IARC.
24. Neumann, H. G. 1980. Dose response relationship in the primary lesion of strong electrophilic carcinogens. Arch. Toxicol. Suppl. 3:69-77.
25. Neutel, C. I., and Buck, C. 1971. Effect of smoking during pregnancy on the risk of cancer in children. J. Natl. Cancer Inst. 47:59-63.
26. Nicolov, I. G., and Chernozemsky, I. N. 1979. Tumors and hyperplastic lesions in Syrian hamsters following transplacental and neonatal treatment with cigarette smoke condensate. J. Cancer Res. Clin. Oncol. 94:249-256.
27. Patrianakos, C., and Hoffmann, D. 1979. Chemical studies on tobacco smoke LXIV. On the analysis of aromatic amines in tobacco smoke. J. Anal. Toxicol. 3:150-154.
28. Perera, F. P. 1988. The significance of DNA and protein adducts in human biomonitoring studies. Mutat. Res. 205:255-269.
29. Pereira, M. A., Lin, L., and Chang, L. W. 1981. Dose dependency of 2-acetylaminofluorene binding to liver DNA and hemoglobin in mice and rats. Toxicol. Appl. Pharmacol. 60:472-478.
30. Sandler, D. P., Everson, R. B., and Wilcox, A. J. 1985. Cancer risk in adulthood from early life exposure to parents smoking. Am. J. Public Health 75:487-492.
31. Shamsuddin, A. K. M., and Gan, R. 1988. Immunocytochemical localization of benzo(a)pyrene DNA adducts in human tissue. Hum. Pathol. 19:309-315.
32. Shugart, L., and Kao, J. 1985. Examination of adduct formation in vivo in the mouse between benzo(a)-pyrene and DNA in skin and hemoglobin of red blood cells. Environ. Health Perspect. 62:223-226.
33. Smith, N., Austen, J., and RoIles, C. J. 1982. Tertiary smoking by the fetus. Lancet 1:1252-1253.
34. Stjernfeldt, M., Berglund, K., and Lindsten, J. 1986. Maternal smoking during pregnancy and risk of childhood cancer. Lancet 1:1350-1352.
35. Van Vunakis, H., Langone, J. J., and Milunsky, A. 1974. Nicotine and cotinine in the amniotic fluid of smokers in the second trimester of pregnancy. Am. J. Obstet. Gynecol. 120:64-66.
36. Vaught, J. B., Gurtoo, H. L., and Parker, N. B. 1979. Effects of smoking on benzo(a)pyrene metabolism by human placental microsomes. Cancer Res. 39:3177-3183.
37. Vineis, P., Caporaso, N., and Tannenbaum, S. R. 1990. The acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking. Cancer Res. 50:3002-3004.